Ruizheng Gene completed a $75 million Series A financing, initiating a comprehensive strategic partnership with TIBET PHARMA and CMS

Zhitong
2025.09.30 02:38

On September 30th, Ruizheng Gene Co., Ltd. announced the completion of a Series A financing totaling USD 75 million and initiated comprehensive strategic cooperation with the Series A investors TIBET PHARMA and CMS

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer